A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors

NCT02115165 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Non-seminomatous Germ-cell Tumors

Interventions

DRUG: Cabazitaxel

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]